Xavant Technology Set to Disrupt Neuropathic Pain Treatment in the UK
(Source: PR Newswire (press release)) PRETORIA, South Africa, April 11, 2018 /PRNewswire/ — Xavant Technology (Pty) Ltd today announced the launch of their Stimpod NMS460 in the U.K. The Stimpod NMS460, a non-invasive neuromodulation device, is focused on the symptomatic relief and management of neuropathic pain as well as an adjunctive …